Steven de Jong
Rijksuniversiteit Groningen
H-index: 66
Europe-Netherlands
Top articles of Steven de Jong
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cells | Leonie De Wilt Bartosz Kamil Sobocki Gerrit Jansen Hessan Tabeian Steven de Jong | 2024 | |
Response of high-grade serous ovarian cancer patient-derived xenograft models to AZD1775/cisplatin combination treatment | Genetic determinants of response to the WEE1 inhibitor AZD1775 in ovarian cancer | M Roorda K Jansen-van Zelm GJ Meersma I Vreeswijk-Baudoin I Eichhorn | 2024 |
Investigating the relationship between negative symptoms and metacognitive functioning in psychosis: An individual participant data meta‐analysis | Nicola McGuire Andrew Gumley Ilanit Hasson‐Ohayon Stephanie Allan Warut Aunjitsakul | 2023/7/10 | |
Genome-wide DNA methylation in relation to ARID1A deficiency in ovarian clear cell carcinoma | Shang Li Gert Jan Meersma Jolanta Kupryjanczyk Steven de Jong G Bea A Wisman | 2023/9/25 | |
Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer | Journal of experimental & clinical cancer research | EC de Heer CE Zois E Bridges B van der Vegt H Sheldon | 2023/6/6 |
Independent transcriptional patterns reveal biological processes associated with disease-free survival in early colorectal cancer | Rudolf Fehrmann Daan Knapen Sara Hone Lopez Derk Jan de Groot Jacco de Haan | 2023/5/8 | |
ArtiCYT-p: a novel synthetic extracellular matrix for generating 3D models in cancer research. | Mechanisms of non-apoptotic TRAIL signalling in NSCLC | Margot de Looff Gert Jan Meersma Frank AE Kruyt Steven de Jong | 2022 |
TRAIL-induces Src mediated MEK/ERK, SMAD3 and β-catenin signalling in apoptosis resistant NSCLC cells | bioRxiv | Margot de Looff Win Sen Heng Steven de Jong Frank AE Kruyt | 2022/8/13 |
Care needs and care consumption in psychosis: a four year longitudinal analysis of guideline concordant care | Connecting needs and care in psychosis | Lukas O Roebroek Jojanneke Bruins David Roe Philippe AEG Delespaul Agna Bartels-Velthuis | 2022 |
Targeting glucose metabolism through inhibition of pyruvate dehydrogenase kinase to improve response to immune-checkpoint inhibition in melanoma | Cancer Research | Jiske F Tiersma Bernardus Evers Barbara M Bakker Steven de Jong Mathilde Jalving | 2022/6/15 |
Glycogen synthesis as potential novel target in triple negative breast cancer: Glycogen synthase 1 expression in human breast cancers and the impact of downregulation on … | Cancer Research | Ellen C De Heer Christos E Zois Esther Bridges Mieke C Zwager Tineke van der Sluis | 2022/6/15 |
Pyruvate dehydrogenase kinase inhibition by dichloroacetate in melanoma cells unveils metabolic vulnerabilities | International Journal of Molecular Sciences | Jiske F Tiersma Bernard Evers Barbara M Bakker Mathilde Jalving Steven de Jong | 2022/3/29 |
Effects of TRAIL treatment and Src on cytokine secretion by resistant A549 NSCLC cells and consequences for immune cell activity | Mechanisms of non-apoptotic TRAIL signalling in NSCLC | Margot de Looff Steven de Jong Frank AE Kruyt | 2022 |
NOTCH signaling limits the response of low-grade serous ovarian cancers to MEK inhibition | Molecular cancer therapeutics | Marta Llaurado Fernandez E Marielle Hijmans Annemiek MC Gennissen Nelson KY Wong Shang Li | 2022/12/2 |
Robust metabolic transcriptional components in 34,494 patient-derived cancer-related samples and cell lines | Cancer & metabolism | VC Leeuwenburgh CG Urzúa-Traslaviña A Bhattacharya MTC Walvoort M Jalving | 2021/12 |
De behandelrelatie | S de Jong HJR Hoenders J Bruins J Th M Steinebach SK Castelein | 2021/4/23 | |
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts | Nature genetics | Xing Yi Woo Jessica Giordano Anuj Srivastava Zi-Ming Zhao Michael W Lloyd | 2021/1 |
Functional RAD51 based assay predicts in vivo PARP inhibitor response in ovarian cancer models beyond BRCA | Homol. Recomb.-Defic. Cancers Approaches Improv. Treat. Patient Sel | Francien Talens VO Teixeira Efraim H Rosenberg Petra M Nederlof Rashmie D Debipersad | 2020 |
The EurOPDX Research Infrastructure: Supporting European and worldwide cancer research with patient-derived xenografts | Cancer Research | Emilie Vinolo Joaquin Arribas Andrea Bertotti Alejandra Bruna Annette T Byrne | 2020/8/15 |
Abstract PO-020: Targeting metabolism to improve response to immune-checkpoint inhibition in melanoma | Cancer Research | Jiske F Tiersma Bernard Evers Barbara M Bakker Steven de Jong Mathilde Jalving | 2020/12/1 |
Co-Authors
